These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34864255)

  • 21. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
    Ahlstrom LA; Mason KV; Mills PC
    J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of dog and cat owners' perceptions of medical treatment for cancer.
    Brønden LB; Rutteman GR; Flagstad A; Teske E
    Vet Rec; 2003 Jan; 152(3):77-80. PubMed ID: 12570310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of doxepin on quality of life in Labradors with laryngeal paralysis: A double-blinded, randomized, placebo-controlled trial.
    Rishniw M; Sammarco J; Glass EN; Cerroni B
    J Vet Intern Med; 2021 Jul; 35(4):1943-1949. PubMed ID: 33998727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy: A prospective, randomized, double-blind, placebo controlled pilot study.
    Pino EHM; Weber MN; de Oliveira LO; Vieira LC; Dos Santos KHS; Liu IP; Gomes HM; Trindade-Gerardi AB; Moreira JCF; Gerardi DG
    Res Vet Sci; 2021 Mar; 135():532-541. PubMed ID: 33221037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tylosin on dogs with suspected tylosin-responsive diarrhea: a placebo-controlled, randomized, double-blinded, prospective clinical trial.
    Kilpinen S; Spillmann T; Syrjä P; Skrzypczak T; Louhelainen M; Westermarck E
    Acta Vet Scand; 2011 Apr; 53(1):26. PubMed ID: 21489311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.
    Finlay J; Wyatt K; Black M
    Vet Comp Oncol; 2017 Mar; 15(1):151-162. PubMed ID: 25864417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life assessment in cancer patients receiving single-agent versus multidrug chemotherapy protocols.
    Bianchi ML; Drudi D; Treggiari E; Catalucci C; Attorri V; Bonazzi I; Valenti P
    Open Vet J; 2021; 11(4):755-763. PubMed ID: 35070873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
    Proksch AL; Unterer S; Truyen U; Hartmann K
    Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
    Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
    J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model.
    Wu SY; Yang WY; Cheng CC; Hsiao MC; Tsai SL; Lin HK; Lin KH; Yuh CH
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase.
    Ko WS; Shen FP; Shih CJ; Chiou YL
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain.
    Fan TM; Charney SC; de Lorimier LP; Garrett LD; Griffon DJ; Gordon-Evans WJ; Wypij JM
    J Vet Intern Med; 2009; 23(1):152-60. PubMed ID: 19175734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine.
    Shaevitz MH; Moore GE; Fulkerson CM
    J Am Vet Med Assoc; 2021 Aug; 259(4):385-391. PubMed ID: 34337965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs.
    Henry CJ; McCaw DL; Brock KV; Stoker AM; Tyler JW; Tate DJ; Higginbotham ML
    J Am Vet Med Assoc; 2001 Nov; 219(9):1238-41. PubMed ID: 11697366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
    Oza AM; Matulonis UA; Malander S; Hudgens S; Sehouli J; Del Campo JM; Berton-Rigaud D; Banerjee S; Scambia G; Berek JS; Lund B; Tinker AV; Hilpert F; Vázquez IP; D'Hondt V; Benigno B; Provencher D; Buscema J; Agarwal S; Mirza MR
    Lancet Oncol; 2018 Aug; 19(8):1117-1125. PubMed ID: 30026000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
    Corral MJ; Moyaert H; Fernandes T; Escalada M; Kira S Tena J; Walters RR; Stegemann MR
    Vet Anaesth Analg; 2021 Nov; 48(6):943-955. PubMed ID: 34565678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Oligo Fucoidan Inhibits Platelet-Derived Growth Factor-Stimulated Proliferation of Airway Smooth Muscle Cells.
    Yang CH; Tsao CF; Ko WS; Chiou YL
    Mar Drugs; 2016 Jan; 14(1):15. PubMed ID: 26761017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
    Segev G; Rojas A; Lavy E; Yaffe M; Aroch I; Baneth G
    Parasit Vectors; 2018 Mar; 11(1):127. PubMed ID: 29506575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.